Turkey is a rapidly growing hub for pharmaceutical manufacturing, development, and global distribution, supported by strong regulatory alignment and advanced production infrastructure. As a professional pharmaceutical products solutions provider in Turkey, Corena delivers end-to-end services covering formulation development, GMP-compliant manufacturing, cold-chain logistics, regulatory documentation, and international supply. Corena supports pharmaceutical companies, distributors, NGOs, and healthcare authorities with safe, traceable, and scalable product solutions. With expertise in temperature-controlled handling, quality assurance, and global market compliance, Corena ensures that pharmaceutical products meet international standards for safety, efficacy, and reliability across diverse global healthcare markets.
Turkey has become one of the most strategically important hubs for global life sciences, driven by its expanding manufacturing capacity, strong regulatory alignment, and rapidly growing export network. Corena stands at the center of this ecosystem, offering end-to-end solutions that cover production, development, cold-chain logistics, compliance, and international distribution. Our integrated approach ensures that partners receive high-quality, reliable, and traceable pharmaceutical products tailored to the needs of diverse global markets.
Pharmaceutical companies today require more than traditional contract manufacturing. They expect a strategic partner capable of managing complex formulation needs, navigating regulatory requirements, ensuring stability and sterility, and enabling scalable global supply. Corena delivers these capabilities with industry-leading infrastructure, experienced teams, and international quality systems.
Our core services span early-stage development through large-scale distribution, providing seamless support for companies aiming to expand their footprint across Europe, the Middle East, Africa, Asia, and Latin America. By combining scientifically robust processes with technologically advanced systems, we guarantee that every pharmaceutical product introduced into the market meets the highest standards of safety, efficacy, and compliance.
Corena’s broad manufacturing capabilities enable the efficient production of sterile and non-sterile formulations across multiple dosage forms. Our vertically integrated ecosystem covers raw material qualification, formulation, filling, packaging, stability, batch release, and logistics. This holistic structure allows us to respond quickly to market demands, optimize time-to-market, and ensure reliability in high-volume production cycles.
Our production sites are equipped with modern cleanroom environments, real-time monitoring systems, and equipment aligning with EU GMP, US FDA, and PIC/S standards. Dedicated areas for liquid, semi-solid, and injectable formats ensure precise control over cross-contamination risks and product integrity.
Key technological capabilities include:
This infrastructure enables high-speed, consistent, and reliable production, positioning Corena as a trusted partner for pharmaceutical production Turkey in regional and global markets.
Corena provides comprehensive development services that support both early-stage innovation and commercial-scale readiness. We collaborate closely with global companies, research centers, and pharmaceutical innovators to transform scientific concepts into fully validated pharmaceutical products.
Our development teams specialize in compatibility studies, formulation refinement, analytical method creation, pilot-scale production, and preparation for regulatory submissions. These services help partners accelerate development timelines while ensuring robust scientific integrity.
Pre-formulation studies form the core of pharmaceutical innovation. Our teams conduct physicochemical profiling, solubility evaluations, degradation pathway identification, and excipient compatibility testing before formulation begins. Once the optimal formulation path is selected, we develop prototype batches and evaluate stability, viscosity, bioavailability, and performance.
Capabilities include:
Through this strategic approach, partners receive scientifically sound formulations ready for further validation and scale-up.
Analytical development ensures the precision and reliability of every pharmaceutical product. Corena designs and validates analytical methods tailored to the specific characteristics of each formulation.
Our analytical services include:
In parallel, we assist with clinical sample preparation, documentation, and analysis to support early-stage clinical testing. This dual capability ensures complete alignment between product development, clinical validation, and future commercial production.
Temperature-sensitive medicines require precise handling from manufacturing to final delivery. Corena’s cold-chain infrastructure ensures consistent environmental control, reducing risks and preserving product efficacy across complex global routes.
Our systems support biologics, vaccines, ophthalmics, and other sensitive categories. With advanced monitoring, strict SOPs, and real-time data tracking, Corena guarantees compliance with international transportation standards.
We operate specialized cold-chain units designed for products requiring +2°C to +8°C, +15°C to +25°C, or deep-freeze conditions. All storage areas are temperature-mapped, equipped with continuous monitoring, and supported by backup energy systems.
Transport solutions include:
These systems allow us to efficiently manage the cold chain management of pharmaceutical products across domestic and international supply chains.
Cold-chain failures can compromise product safety and lead to regulatory non-compliance. Our risk management framework incorporates predictive monitoring, deviation analysis, and data-driven quality controls. We use real-time alarms, electronic logs, and corrective action protocols to ensure uninterrupted compliance.
This secure infrastructure positions Corena among the region’s dependable pharmaceutical cold chain products services providers, supporting partners who demand consistency, transparency, and precision.
Regulatory compliance is at the core of our operations. Corena’s quality teams ensure that every product meets global legal, technical, and safety standards. Our documentation systems align with GMP, GDP, ISO 13485, PIC/S, and other international frameworks.
We also support partners through certification, market entry, and regulatory inspections, offering reliable pathways for international approvals.
Corena prepares, manages, and oversees extensive regulatory documentation for global submissions. This includes product dossiers, manufacturing records, safety data, validation documents, and packaging details.
Our support covers:
We ensure that every partner receives a fully compliant pharmaceutical product certificate ready for local or international market submission.
Sterile products require rigorous testing to ensure safety. Corena conducts sterility monitoring, endotoxin testing, microbial limit tests, and environmental assessments in compliance with pharmacopeial standards.
Our certified labs deliver:
These services safeguard product quality and ensure that every batch meets strict global standards.
Beyond manufacturing and development, Corena operates as a reliable pharmaceutical products wholesaler with extensive reach across multiple continents. Our wholesale operations connect manufacturers with hospitals, distributors, NGOs, government agencies, and private sector buyers worldwide.
Corena’s distribution network spans Europe, the Middle East, Africa, and Asia. We work with licensed partners, customs agents, and regulated warehouses to ensure compliant and seamless international shipment. The network is supported by digital tracking systems, temperature-controlled logistics, and integrated documentation management, enabling smooth export processes for diverse markets.
Our expertise allows partners to expand into new regions while maintaining full visibility over product movement and regulatory requirements.
We specialize in the coordination, planning, and fulfillment of large-scale pharmaceutical deliveries. Our systems support demand forecasting, buffer-stock management, and multi-batch supply planning. This enables us to meet the growing needs of the Global medicine supply ecosystem and ensure continuity even during periods of high demand.
Whether supplying government tenders, humanitarian programs, or private distributors, Corena provides a consistent, reliable, and compliant high-volume supply structure.
Corena’s comprehensive pharmaceutical solutions—from development and production to certification, cold-chain logistics, and global wholesale—offer unmatched value to international partners seeking quality, reliability, and scalability. With advanced infrastructure, strict quality systems, and a global distribution capability, Corena ensures the seamless delivery of compliant and high-performing pharmaceutical products to markets around the world.
Corena is a global provider of Healthcare Solutions, offering pharmaceuticals, medical devices, dental, veterinary, and laboratory products. Since 2009, we have supported emergency response, rare disease treatments, and clinical trial supplies with reliable and customer-focused services.